Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 8/20 | 0.54 |
| ▸ | DRD2 | P14416 | 7/20 | 0.54 |
| ▸ | DRD3 | P35462 | 7/20 | 0.54 |
| ▸ | HTR1B | P28222 | 2/20 | 0.48 |
| ▸ | HTR1D | P28221 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11894889 | 0.89 | DRD4 (0.46) | KCNA3DRD4DRD2DRD3HTR1B | |
| SCHEMBL1369606 | 0.85 | LTA4H (0.48) | KCNA3DRD4DRD2DRD3HTR1B | |
| SCHEMBL4345362 | 0.84 | DRD4 (0.66) | DRD4GAAMAOABCHE | |
| SCHEMBL8078109 | 0.82 | DRD4 (0.48) | KCNA3DRD4DRD2DRD3HTR1B | |
| SCHEMBL5714557 | 0.82 | ALDH1A1 (0.54) | KCNA3DRD4DRD2DRD3HTR1B | |
| SCHEMBL18517166 | 0.81 | KCNA3 (0.52) | KCNA3DRD4DRD2DRD3HTR1B | |
| SCHEMBL13588393 | 0.80 | MAOA (0.47) | KCNA3DRD4DRD2DRD3HTR1B | |
| SCHEMBL13758826 | 0.80 | DRD4 (0.42) | KCNA3DRD4DRD2DRD3HTR1B | |
| SCHEMBL25060330 | 0.79 | TAAR1 (0.50) | KCNA3DRD4DRD2DRD3HTR1B | |
| SCHEMBL11895736 | 0.79 | HTR1B (0.61) | KCNA3DRD4DRD2DRD3HTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2379473-B1 | DIACENAPHTHO[1,2-B:1',2'-K]CHRYSENE DERIVATIVE | CANON KK (JP) | 2017-02-22 | — | — | EP | claimed |
| US-9000107-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2015-04-07 | — | — | US | claimed |
| US-20120196995-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2012-08-02 | — | — | US | claimed |
| WO-2024142881-A1 | METAL COMPLEX AND ORGANIC ELECTROLUMINESCENT ELEMENT | キヤノン株式会社 | 2024-07-04 | — | — | WO | disclosed |
| CN-118265686-A | Organic compound, organic light-emitting element, display device, photoelectric conversion device, electronic device, illumination device, moving body, and exposure light source | 佳能株式会社 | 2024-06-28 | — | — | CN | disclosed |
| WO-2024116908-A1 | ORGANOMETALLIC COMPLEX AND ORGANIC LIGHT EMITTING ELEMENT | キヤノン株式会社 | 2024-06-06 | — | — | WO | disclosed |
| CN-118103381-A | Organic compound and organic light-emitting device | 佳能株式会社 | 2024-05-28 | — | — | CN | disclosed |
| US-20240172553-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2024-05-23 | — | — | US | disclosed |
| WO-2024106218-A1 | ORGANIC METAL COMPLEX AND ORGANIC LIGHT-EMITTING ELEMENT | キヤノン株式会社 | 2024-05-23 | — | — | WO | disclosed |
| EP-4372067-A1 | ORGANOMETALLIC COMPLEX AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2024-05-22 | — | — | EP | disclosed |
| CN-118047814-A | Organometallic complex and organic light-emitting element | 佳能株式会社 | 2024-05-17 | — | — | CN | disclosed |
| US-20060121312-A1 | Fluorene compound and organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2006-06-08 | — | — | US | disclosed |
| US-20060113528-A1 | Organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2006-06-01 | — | — | US | disclosed |
| US-20060115678-A1 | Aminoanthryl derivative-substituted pyrene compound and organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2006-06-01 | — | — | US | disclosed |
| US-20050099115-A1 | Substituted anthryl derivative and electoluminescence device using the same | CANON KABUSHIKI KAISHA (JP) | 2005-05-12 | — | — | US | disclosed |
| CN-1578556-A | Organic light emitting element | CANON KK (JP) | 2005-02-09 | — | — | CN | disclosed |
| CN-1576265-A | Substituted anthracene derivative and organic light-emitting element using same | CANON KK (JP) | 2005-02-09 | — | — | CN | disclosed |
| WO-2005000787-A1 | AMINOANTHRYL DERIVATIVE SUBSTITUTION COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2005-01-06 | — | — | WO | disclosed |
| US-20040263067-A1 | Anthryl derivative group substituted compound, and organic luminescent device making use of same | CANON KABUSHIKI KAISHA (JP) | 2004-12-30 | — | — | US | disclosed |
| US-20040265632-A1 | Organic electroluminescent device | CANON KABUSHIKI KAISHA (JP) | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060121312-A1 | Fluorene compound and organic light-emitting device | LEF1, AFF1, FLI1 | KCNA3 1181/4885DRD4 689/4885DRD2 545/4885 |
| US-20050099115-A1 | Substituted anthryl derivative and electoluminescence device using the same | ALAD, ERAL1, LAGE3 | KCNA3 3284/4885DRD4 2938/4885DRD2 3315/4885 |
| US-20240172553-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT | NOM1, L1CAM, AP2M1 | KCNA3 753/4885DRD4 873/4885DRD2 1220/4885 |
| US-20060115678-A1 | Aminoanthryl derivative-substituted pyrene compound and organic light-emitting device | ALAD, PAH, PPOX | KCNA3 1645/4885DRD4 2523/4885DRD2 2294/4885 |
| US-20040263067-A1 | Anthryl derivative group substituted compound, and organic luminescent device making use of same | ALAD, AAAS, NLRP1 | KCNA3 867/4885DRD4 2366/4885DRD2 1851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.